Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of New Drugs
1003-3734
2009 Issue 13
Study on preparation and physicochemical properties of etoposide-phospholipid complex
wu zhong-bin1; 2; guo dan1; chen jian-ming1(school of pharmacy; second military medical university; shanghai 200433; china)
..............page:1250-1256
Optimal fermentation of a new Micromonospora C3509 producing high active anti-tumor antibiotic
zhang wen-jun; zhao chun-yan; fan cui-min; wang yu-feng; li dian-dong; shao rong-guang(institute of medicinal biotechnology; peking union medical college and chinese academy of medical science; beijing 100050; china)
..............page:1245-1249
Efficacy of anus plugging with oxycodone-acetaminophen tablets in the treatment of moderate and serious cancer pain
li gui-yuan; wang dong-ling; yi sheng-ming(department of oncology; tongji hospital; tongji university; shanghai 200065; china)
..............page:1220-1222
Analysis of antineoplastic drug application in Nanjing city during 2007
luo can; feng lin(department of pharmacy; first affiliated hospital of nanjing medical university; nanjing 210029; china)
..............page:1277-1280
Effects of sodium hyaluronate on the physicochemical properties of ophthalmic thermosensitive in situ ge1s of diclofenac sodium
ju feng-ge; zhu zhao-jing; ma li-li(school of pharmacy; chongqing medical university; chongqing 400016; china)
..............page:1237-1242
Supplemental submission of application for investigational new drugs in China
yang zhi-min; wen bao-shu; shi ji-feng; he yan-ping; yang jian-hong; feng yi(center for drug evaluation of sfda; beijing 100038; china)
..............page:1193-1195,1242
The present situation and development direction of the research for polymorphic drugs in China
qi ang gui-fen; l yang; du guan-hua(institute of materia medica; chinese academy of medical sciences and peking union medical college; beijing 100050; china)
..............page:1196-1200
Preparation of coated levalbuterol hydrochloride matrix sustained-released tablet
zhang shu; li n hua-qing; deng hong; xu liang-kui; yu chu-qin(institute of medica; guangdong pharmaceutical university; guangdong provincial key laboratory of advanced drug delivery; guangzhou 510006; china)
..............page:1257-1261
Analysis of 101 cases for the treatment of hiccup with granisetron
zhang jun-kai; kang gou-qiang; bai xiu-li; gao fu-lan(the first department of internal medicine; huanghua people s hospital of hebei province; huanghua 061100; china)
..............page:1211-1212,1236
Optimazation of extraction of total alkaloids from alpine yarrow herb
wang ru-wei1; wang li1; zhu hui-qin2; li u bao-hu3(1 general hospital of ningxia coal industry; shizuishan 753000; china; 2 ningxia institute for drug control; yinchuan 750001; china; 3 national medicine limited company of ningxia baoli; zhongwei 755000; china)
..............page:1274-1276
WINDOW OF NEW DRUGS
..............page:1180-1181
Compound Danshen Diwan combined with fluvastatin inhibits formation of carotid atherosclerotic plaques
dong bing-qing1; ge bin1; feng xia1; chen ai-fang2(1 department of cardiology; the affiliated hospital of taishan medical college; taian 271000; china; 2 department of ultrasound; the affiliated hospital of taishan medical college; taian 271000; china)
..............page:1217-1219
Analgesic effect of oxycodone-acetaminophen tablets on moderate or severe cancer pain
wang li-bing1; hong yu2; zheng jian-xing1(1 tangshan clinical medical college; hebei medical university; tangshan 063000; china; 2 tangshan peoples s hospital; tangshan 063000; china)
..............page:1223-1224
Progress in the research of the interleukin-1 blocker rilonacept
shi zheng-yuan1; 2; cao guo-ying1; fu de-xing1; hu xin1; chen xiao-hui2; bi kai-shun2(1 department of clinical pharmacology; beijing hospital; beijing 100730; china; 2 shenyang pharmaceutical university; shenyang 110016; china)
..............page:1201-1203,1210
ben qi dao du
..............page:1173
Pharmacology and clinical evaluation of rufinamide,a new antiepileptic drugs
feng yu-fei1; xu qiao-ling2; li wen-ying1; fu de-xing1(1 department of pharmacy; beijing hospital; beijing 100730; china; 2 health care division; security bureau of head quaters of the general staff; beijing 100017; china)
..............page:1182-1185
Effects of rapamycin on collagen type Ⅰ expression in rat myocardial cell induced by CVB 3
chen chun-yuan; yang min; cai zi-li; sun yue-n ; yang zuo-cheng(department of paediatrics; 3rd xiangya hospital; central south university; changsha 410013; china)
..............page:1225-1230
Application of defense principle of publicly known technology in the drug patent infringement litigation
chen jing; ji ang bin; shi lu-wen(department of pharmacy administration and clinical pharmacy; school of pharmacy; peking university; beijing 100191; china)
..............page:1186-1188,1273
Management measures of drug risk and its application in the case of Lotronex
wei jing1; 2; pan wei-san3; yang yue1(1 school of business administration; shenyang pharmaceutical university; shenyang 110016; china; 2 liaoning food and drug administration technical evaluation center; shenyang 110003; china; 3 school of pharmacy; shenyang pharmaceutical university; shenyang 110016; china)
..............page:1189-1192
Classification and application of proteins from snake venom
chen nian1; fu xiao-yan2; ji ang wei-jian2; zhao shu-jin2(1 college of chinese materia medica; guangzhou university of chinese medicine; guangzhou 510006; 2 general hospital of guangzhou military command; guangzhou 510010; china))
..............page:1204-1210
In vivo pharmacokinetics and distribution of nimodipine microemulsion injection in mice
zhou li-juan1; 2; chen xi2; li u qing-fei2; luo guo-an2(1 department of pharmacy; zhengzhou central hospital; zhengzhou 450007; china; ina; 2 institute of biomedicine; tsinghua university; beijing 100084; china)
..............page:1231-1236
Preparation and influence factors of salbutamol sulfate resin
zhang xuan-yi1; zhang xiang-rong1; l juan-li2; lei yang1; li u wei1; pan wei-san1(1 department of pharmaceutics; shenyang pharmaceutical university; shenyang 110016; china; 2 department of pharmacy; general hospital of chinese people s armed police forces; beijing 100039; china)
..............page:1262-1265
Co-extraction and clathration technology of volatile oil in the medicine "Zha Chong Shi San Wei Wan" and its quality criteria
zheng rui-qiang; wang lan-yin2; l wei-feng1; gao xiang-dong1(1 school of life science and technology; china pharmaceutical university; nanjing 210009; china; 2 zhongmeng pharmaceutical co.; ltd; hohhot 010110; china)
..............page:1266-1273
Synthesis of doxercalciferol
sun bo; xu hong gui; wen peng; lu qun(school of life science and engineering; southwest jiaotong university; chengdu 610031; china)
..............page:1243-1244,1276
Effect of Fufang Danshen Diwan on the cognitive function of diabetic patients complicated with coronary heart disease
li n jia-yi1; li u jia-he2; li u xian-hua1; gu dong-fang1(1 jiucheng hospital; anhui province; anqing 246220; china; 2 zhejiang quzhou people s hospital; zhejiang province; quzhou 324000; china)
..............page:1213-1216